Literature DB >> 2350160

Stochastic theory of oncogenesis.

D J Derkinderen1, O J Boxma, J W Koten, W Den Otter.   

Abstract

It is generally agreed that most malignancies, particularly those that arise "spontaneously", are caused by randomly occurring mutations at specific sites of the genome. Hence oncogenesis of these spontaneous tumors can be described by stochastic mathematical models. In this paper we offer a mathematical approach to oncogenesis. A stochastic model was developed to calculate the number of mutations required for malignant transformation. This model demonstrates that the two hit model, as originally proposed by Knudson for retinoblastoma in children, is not tenable for tumors in adults. Our results show that malignant transformation is more likely to be due to a specific set of four mutations. This stochastic model is compatible with most current views on oncogenesis and most phenomena in oncology.

Entities:  

Mesh:

Year:  1990        PMID: 2350160

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Clinicopathological characteristics and prognosis of stage IV colorectal cancer.

Authors:  Norikatsu Miyoshi; Masayuki Ohue; Tatsushi Shingai; Shingo Noura; Keijiro Sugimura; Hirofumi Akita; Kunihito Gotoh; Masaaki Motoori; Hidenori Takahashi; Kentaro Kishi; Jiro Okami; Shigeru Marubashi; Yoshiyuki Fujiwara; Masahiko Higashiyama; Masahiko Yano
Journal:  Mol Clin Oncol       Date:  2015-07-08

Review 2.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

3.  Alternative models for early onset of childhood leukaemia.

Authors:  T E Wheldon; R J Mairs; A Barrett; E G Wheldon; B E Gibson
Journal:  Br J Cancer Suppl       Date:  1992-08

4.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Authors:  N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.